Thulium Revenue and Competitors

Cracow , Poland

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Thulium's estimated annual revenue is currently $2.1M per year.(i)
  • Thulium's estimated revenue per employee is $58,000

Employee Data

  • Thulium has 36 Employees.(i)

Thulium's People

NameTitleEmail/Phone
1
CTO / Co-founderReveal Email/Phone
2
DevOps/Admin LeadReveal Email/Phone
3
Customer Support Team LeaderReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$338.5M86155%$484M$6.1B
#2
$1250M6469-1%$85.5M$12.2B
#3
$36.2M232-6%$28MN/A
#4
$15.5M11154%N/AN/A
#5
N/A19N/AN/AN/A
#6
$4.4M38N/AN/AN/A
#7
$29.8M198136%$234M$1B
#8
$0.5M11N/AN/AN/A
#9
$42.9M28518%$45MN/A
#10
$0.3M4N/AN/AN/A
#11
$271.2M1336N/AN/AN/A
#12
$13.9M96N/AN/AN/A
#13
$2.8M28N/AN/AN/A
#14
$0.3M4N/AN/AN/A
#15
$0.9M10N/AN/AN/A
#16
$31.6M2109%$168MN/A
#17
$1.5M17N/AN/AN/A
#18
$24.6M154N/AN/AN/A
#19
$0.4M6N/AN/AN/A
#20
$0.3M4N/AN/AN/A
Add Company

What Is Thulium?

keywords:N/A

N/A

Total Funding

36

Number of Employees

$2.1M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Thulium News

2022-04-13 - Global Thulium(III) Acetylacetonate Market 2022 – Industry ...

Global Thulium(III) Acetylacetonate Market 2022 – Industry Analysis, Segments, Value Chain and Key Trends 2028 · North America (United States,...

2022-04-06 - Change in postoperative storage symptoms and de novo urge-incontinence after Thulium: YAG laser enucleation of the prostate: results from a prospective, multicenter study

OBJECTIVES: To assess the change of storage symptoms and their impact on quality of life in men undergoing Thulium: YAG laser enucleation of the...

2022-03-30 - Thulium fibre laser superior to holmium: YAG for clearing kidney stones: Study

Norway: A new study published in European Urology found that by utilizing thulium fiber laser (TFL) instead of Holmium:...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A366%N/A
#2
$8.2M56-2%N/A
#3
$3.9M603%N/A
#4
$15.6M760%N/A
#5
$13.1M90-10%N/A